The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5

被引:99
|
作者
Zwick, MB
Komori, HK
Stanfield, RL
Church, S
Wang, M
Parren, PWHI
Kunert, R
Katinger, H
Wilson, IA
Burton, DR
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[4] Univ Nat Resources, Inst Appl Microbiol, Vienna, Austria
关键词
D O I
10.1128/JVI.78.6.3155-3161.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human monoclonal antibody 2F5 neutralizes primary human immunodeficiency virus type 1 (HfV-1) with rare breadth and potency. A crystal structure of a complex of 2F5 and a peptide corresponding to its core epitope on gp41, ELDKWAS, revealed that the peptide interacts with residues at the base of the unusually long (22-residue) third complementarity-determining region of the heavy chain (CDR H3) but not the apex. Here, we perform alanine-scanning mutagenesis across CDR H3 and make additional substitutions of selected residues to map the paratope of Fab 2F5. Substitution of residues from the base of the H3 loop or from CDRs H1, H2, and L3, which are proximal to the peptide, significantly diminished the affinity of Fab 2F5 for gp41 and a short peptide containing the 2F5 core motif. However, nonconservative substitutions to a phenylalanine residue at the apex of the H3 loop also markedly decreased 2F5 binding to both gp41 and the peptide, suggesting that recognition of the core epitope is crucially dependent on features at the apex of the H3 loop. Furthermore, substitution at the apex of the H3 loop had an even more pronounced effect on the neutralizing activity of 2F5 against three sensitive HIV-1. These observations present a challenge to vaccine strategies based on peptide mimics of the linear epitope.
引用
收藏
页码:3155 / 3161
页数:7
相关论文
共 50 条
  • [1] Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications
    Bryson, Steve
    Julien, Jean-Philippe
    Hynes, Rosemary C.
    Pai, Emil F.
    JOURNAL OF VIROLOGY, 2009, 83 (22) : 11862 - 11875
  • [2] Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region
    Ofek, Gilad
    McKee, Krisha
    Yang, Yongping
    Yang, Zhi-Yong
    Skinner, Jeff
    Guenaga, F. Javier
    Wyatt, Richard
    Zwick, Michael B.
    Nabel, Gary J.
    Mascola, John R.
    Kwong, Peter D.
    JOURNAL OF VIROLOGY, 2010, 84 (06) : 2955 - 2962
  • [3] The Antibody 2F5 Third Complementarity-Determining Region of the Heavy Chain (CDRH3) Displays Length Plasticity for Binding and Neutralization
    Guenaga, F.
    Wyatt, R.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A45 - A45
  • [4] Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
    Julien, Jean-Philippe
    Huarte, Nerea
    Maeso, Ruben
    Taneva, Stefka G.
    Cunningham, Annie
    Nieva, Jose L.
    Pai, Emil F.
    JOURNAL OF VIROLOGY, 2010, 84 (09) : 4136 - 4147
  • [5] Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5
    Ou, W
    Lu, N
    Yu, SS
    Silver, J
    JOURNAL OF VIROLOGY, 2006, 80 (05) : 2539 - 2547
  • [6] The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5
    Huarte, Nerea
    Lorizate, Maier
    Maeso, Ruben
    Kunert, Renate
    Arranz, Rocio
    Valpuesta, Jose M.
    Nieva, Jose L.
    JOURNAL OF VIROLOGY, 2008, 82 (18) : 8986 - 8996
  • [7] Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain
    Almagro, Juan Carlos
    Raghunathan, Gopalan
    Beil, Eric
    Janecki, Dariusz J.
    Chen, Qiang
    Dinh, Thai
    LaCombe, Ann
    Connor, Judy
    Ware, Mark
    Kim, Paul H.
    Swanson, Ronald V.
    Fransson, Johan
    JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (03) : 125 - 135
  • [8] Membrane pore formation by the human immunodeficiency virus type-1 neutralizing anti-gp41 antibody 2F5
    Maeso, Ruben
    Kunert, Renate
    Nieva, Jose L.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2010, 163 : S46 - S46
  • [9] Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody
    Sánchez-Martínez, S
    Lorizate, M
    Katinger, H
    Kunert, R
    Basañez, G
    Nieva, JL
    FEBS LETTERS, 2006, 580 (09): : 2395 - 2399
  • [10] Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
    Ofek, G
    Tang, M
    Sambor, A
    Katinger, H
    Mascola, JR
    Wyatt, R
    Kwong, PD
    JOURNAL OF VIROLOGY, 2004, 78 (19) : 10724 - 10737